T1	p 140 172	patients undergoing laparatomy .
T2	p 450 568	patients undergoing laparotomy . METHODS Eighty patients ( 18 to 65 years of age ) undergoing elective laparotomy were
T3	p 618 625	group )
T4	p 1921 1953	patients undergoing laparotomy .
T5	p 2049 2081	patients undergoing laparatomy .
T6	i 21 98	preoperative oral pregabalin and perioperative intravenous lidocaine infusion
T7	i 116 124	morphine
T8	i 236 300	oral pregabalin and perioperative intravenous lidocaine infusion
T9	i 318 326	morphine
T10	i 553 563	laparotomy
T11	i 626 709	: group C , placebo capsules and normal saline infusion perioperatively ( control )
T12	i 722 841	placebo capsules and lidocaine 1 mg?kg intravenous bolus dose followed by 2 mg?kg?h infusion until skin closure ; group
T13	i 853 913	oral pregabalin and normal saline infusion perioperatively ;
T14	i 945 993	oral pregabalin and lidocaine 2 mg?kg?h infusion
T15	i 1322 1330	Morphine
T16	i 1615 1670	oral pregabalin and perioperative intravenous lidocaine
T17	i 1735 1745	pregabalin
T18	i 1756 1764	morphine
T19	i 1807 1834	lidocaine infusion hastened
T20	i 1979 1989	pregabalin
T21	i 1998 2015	without lidocaine
T22	o 102 136	postoperative morphine requirement
T23	o 304 446	postoperative morphine requirement , adverse effects , patients ' satisfaction , mobilization , time to first defecation and time to discharge
T24	o 1005 1213	closure . Hemodynamic parameters , visual analogue scale ( VAS ) scores , analgesic consumption , side effects , time to mobilization , time to first defecation , time to discharge and patients ' satisfaction
T25	o 1238 1248	VAS scores
T26	o 1331 1342	consumption
T27	o 1405 1424	Incidence of nausea
T28	o 1475 1516	Time to first defecation and mobilization
T29	o 1690 1734	postoperative VAS scores . Preoperative oral
T30	o 1756 1879	morphine requirement and perioperative intravenous lidocaine infusion hastened gastrointestinal motility and mobilization ,
T31	o 1898 1917	incidence of nausea
T32	o 2034 2045	pain relief